CEBPZ and Alzheimer disease: Mouse models have demonstrated that GMB disruption can trigger neurovascular dysfunction related to AD risk [19], suggesting that microbial pathogens may influence AD pathogenesis through chronic inflammation to disrupt the neurovascular unit [20], alter metabolite production to affect vascular function [21,22], or affect CBF regulation directly [23].